Global Biotech Breakthroughs

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥29.9b

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Arcturus Therapeutics Holdings

Market Cap: US$556.1m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Zai Lab

Market Cap: US$3.8b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Alector

Market Cap: US$303.6m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

GeoVax Labs

Market Cap: US$13.7m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

Immunic

Market Cap: US$94.7m

A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.

Geron

Market Cap: US$899.6m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Formycon

Market Cap: €447.8m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Aprea Therapeutics

Market Cap: US$8.5m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Valneva

Market Cap: €858.0m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Seegene

Market Cap: ₩1.2t

Manufactures and sells molecular diagnostics products worldwide.

Oxford Biomedica

Market Cap: UK£716.3m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

ABL Bio

Market Cap: ₩5.3t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Aroa Biosurgery

Market Cap: AU$232.9m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

PeptiDream

Market Cap: JP¥196.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Mirum Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Paradigm Biopharmaceuticals

Market Cap: AU$150.3m

Engages in the research and development of therapeutic products for human use in Australia.

Apellis Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Organogenesis Holdings

Market Cap: US$537.9m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Natera

Market Cap: US$22.2b

A diagnostics company, provides molecular testing services worldwide.